Views & Analysis Unlocking the healing power of music Continuing our series on how digital health is fighting back against COVID
News Bharat Biotech begins trial of COVID-19 vaccine in India as ... Bharat Biotech is to begin trials of a coronavirus vaccine in India as the country faces a rapidly growing outbreak.
Views & Analysis How necessity is driving the ‘inevitable transformation’ of ... From virtual conferences to CPD webinars, medical education moved online when COVID-19 hit. But is this new way of learning here to stay?
News Gilead finally breaks its silence on remdesivir’s price After weeks of speculation, Gilead Sciences has revealed its pricing plans for coronavirus drug remdesivir – and the rationale behind its decision.
Views & Analysis The real impact of COVID-19 on emerging markets When COVID-19 began to spread uncontrollably, numbers of confirmed cases initially grew most quickly in developed economies across China, Europe and then the US.
Views & Analysis Coronavirus pharma news roundup - 26/06/20 As COVID-19 drugs vie for approval, we highlight the top pharma R&D, digital and market access news for coronavirus from the past week.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
